Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FGK9Z
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,676
Award facts
- Contract value 100% obligated
- $3,676.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on December 9, 2025, for the supply of Dupixent 300 mg/2 ml syringes. The contract, valued at $3,676.08 with firm fixed pricing, is scheduled for completion by December 10, 2025, and represents a non-competitive, non-set-aside award. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
The Defense Logistics Agency's Medical Supply Chain utilizes these delivery orders to procure critical medications and medical commodities for the Department of Defense and other federal healthcare entities, including the Defense Health Agency and U.S. Coast Guard. Dupixent (dupilumab) is a biologic medication used to treat atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps, making this procurement relevant to military medical treatment facilities and veteran healthcare systems. As a child contract under the larger DLA Troop Support Medical IDC, this delivery order demonstrates AmerisourceBergen's continued role as a critical pharmaceutical vendor supporting federal medical procurement requirements through established contractual frameworks.
Quick answers
Who was awarded contract SPE2DR26FGK9Z?
SPE2DR26FGK9Z was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26FGK9Z worth?
The government has obligated $3,676 on SPE2DR26FGK9Z.
Is contract SPE2DR26FGK9Z an order under another contract?
Yes. SPE2DR26FGK9Z is a delivery order under SPE2DR25D1002, an indefinite delivery contract.
Was contract SPE2DR26FGK9Z competed?
The extent of competition for SPE2DR26FGK9Z was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award